drugset / Trial / NCT00392574

Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea

NCT00392574

Phase 3 Completed 282 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this pivotal Phase III study is to investigate the safety and efficacy of prulifloxacin versus placebo in the treatment of subjects with acute bacterial gastroenteritis.

Timeline

Start
2006-08
Primary completion
2008-02
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Prulifloxacin Small molecule

Indications